Copegus and Daklinza drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Copegus (ribavirin) and Daklinza (daclatasvir dihydrochloride). Common drug interactions include drug ineffective among females and hyperbilirubinaemia among males.
The phase IV clinical study analyzes what interactions people have when they take Copegus and Daklinza. It is created by eHealthMe based on reports of 132 people who take the same drugs from the FDA, and is updated regularly.
What is Copegus?
Copegus has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 15,115 Copegus users. Check the latest studies of Copegus.
What is Daklinza?
Daklinza has active ingredients of daclatasvir dihydrochloride. eHealthMe is studying from 3,312 Daklinza users. Check the latest studies of Daklinza.
132 people who take Copegus and Daklinza together, and have interactions are studied.
What are the common drug interactions of Copegus and Daklinza, by gender? *
What are the common drug interactions of Copegus and Daklinza, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Copegus and Daklinza?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Copegus and Daklinza:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Copegus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Daklinza:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Copegus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Daklinza and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on ribavirin and daclatasvir dihydrochloride (the active ingredients of Copegus and Daklinza, respectively), and Copegus and Daklinza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Pitavastatin Calcium and Xtandi - now
- Drug interactions of Hydramine and Flecainide Acetate - 17 seconds ago
- Schizophrenia and Fungal Nail Infection - 30 seconds ago
- Could Clobetasol Propionate cause Head Injury? - 33 seconds ago
- Drug interactions of Flonase and Verelan - 40 seconds ago
- Could Enalapril Maleate And Hydrochlorothiazide cause Acute Kidney Failure? - 45 seconds ago
- Drug interactions of Flovent and Ms Contin - 55 seconds ago
- Drug interactions of Pantoprazole and Ubidecarenone - a minute ago
- Drug interactions of Sodium Bicarbonate and Gadavist - a minute ago
- Could Hydroxyzine cause Product Taste Abnormal? - a minute ago